Randomized, 1‐year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice‐daily premixed insulin versus basal insulin with either basal‐plus one prandial insulin or basal‐bolus up to three prandial injections
Authors:
- 11 October 2013
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 16 (5) , 396-402
Abstract
Aim: Many patients with type 2 diabetes mellitus (T2DM) initiate insulin therapy when other treatments fail; how best to do this is poorly defined.Methods: People with T2DM [n = 588; glycated haemoglobin A1C (A1C) >7.0%, mean baseline 9.4%] were randomized to twice‐daily premixed protamine‐aspart/aspart insulin (PM − 2), once‐daily insulin glargine plus zero to one prandial insulin glulisine injection (G + 1), or insulin glargine plus zero to three prandial injections (G + 3). Insulin was titrated for 60 weeks. Efficacy and safety outcomes were assessed.Results: Discontinuation rates were 53 of the 194 (27%), 44 of the 194 (23%) and 38 of the 194 (20%), for PM − 2, G + 1 and G + 3. Glycaemic control improved in all groups (A1C 7.2 ± 1.37, 7.1 ± 1.68 and 7.0 ± 1.21% at 60 weeks; 7.5 ± 1.29, 7.2 ± 1.62 and 7.2 ± 1.63% at endpoint). G + 1 was statistically non‐inferior to PM − 2 in reducing A1C. G + 3 was slightly superior to PM − 2 in attaining <7.0% at 60 weeks, but only when the analysis included Good Clinical Practice non‐adherent sites. Hypoglycaemia with plasma glucose <2.8 mmol/l was more frequent with PM − 2 versus G + 1 and G + 3; [adjusted incidence: 46 (p = 0.0087) vs. 33 (p = 0.0045) and 31.5%; events per patient‐year: 1.9 vs. 0.8 and 0.9, p ≤ 0.0001]. Insulin dosage and weight‐gain were similar.Conclusion: Basal insulin plus a single prandial injection is as effective in improving glycaemic control as premixed insulin. Full basal‐prandial therapy is only slightly more effective than premixed insulin. Stepwise basal‐prandial regimens improve glycaemic control with less hypoglycaemia than twice‐daily premixed insulin.Keywords
This publication has 13 references indexed in Scilit:
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachDiabetes Care, 2012
- Effects of initiation and titration of a single pre‐prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6‐month ‘proof‐of‐concept' studyDiabetes, Obesity and Metabolism, 2011
- A Stepwise Approach to Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Basal Insulin Treatment FailureEndocrine Practice, 2011
- Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 DiabetesDiabetes Care, 2011
- Comparison between a basal‐bolus and a premixed insulin regimen in individuals with type 2 diabetes–results of the GINGER studyDiabetes, Obesity and Metabolism, 2009
- Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trialThe Lancet, 2008
- When basal insulin therapy in type 2 diabetes mellitus is not enough—what next?Diabetes/Metabolism Research and Reviews, 2007
- Basal insulin or premix analogue therapy in type 2 diabetes patientsEuropean Journal of Internal Medicine, 2007
- Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET studyDiabetologia, 2006
- Initiating Insulin Therapy in Type 2 DiabetesDiabetes Care, 2005